• Dr. Paul R. Billings, Executive Chairman, Board certified internist and clinical geneticist, Dr. Paul R. Billings serves as executive Chairman of Melanoma Diagnostics, Inc., and Chief Medical Officer of Life Technologies Corporation. Dr. Billings brings extensive expertise and health care experience in the areas of genomics and molecular medicine. Most recently, he served as Director and Chief Scientific Officer of the Genomic Medicine Institute at El Camino Hospital, the largest community hospital in the Silicon Valley. He was a member of the United States Department of Health and Human Services Secretary's Advisory Committee on Genetics, Health and Society. He currently serves on the Scientific Advisory Board of the Food and Drug Administration, the Genomic Medicine Advisory Committee at the Department of Veterans Affairs, and the IOM Roundtable on Genomics. Dr. Billings has had a distinguished career as a physician and researcher. He has been a founder or chief executive officer of companies involved in genetic and diagnostic medicine, including GeneSage, Omicia and CELLective Dx Corporation. Previously, he was senior vice president for corporate development at Laboratory Corporation of America Holdings (LabCorp). He has held academic appointments at some of the most prestigious universities in the United States, including Harvard Medical School, U.C. San Francisco, Stanford University School of Medicine and U. C. Berkeley, and has served as a physician at a number of prestigious medical centers. He is the author of nearly 200 publications and books on experimental and clinical medicine. Dr. Billings holds an M.D. from Harvard Medical School and a Ph.D. in immunology, also from Harvard University
• Dr. Kashani-Sabet, Founding Scientist was formerly Director of UC San Francisco Melanoma Center and the Zackheim Endowed Chair in Cutaneous Oncology. He is an internationally recognized leader in the molecular assessment of melanoma, and has authored numerous peer-reviewed publications focused on tumor progression markers.
  
  
  
  
• Mr. Bijan Farhangui, Chief Operating Officer, has launched a number of successful medical diagnostic products nationally and internationally. He has had held executive management positions with ADAC Laboratories, Becton-Dickinson, and Abbott Laboratories.
  
  
  
  
  
  
• Dr. J. P. Mainguy, Manager of Global Regulatory and Safety, is with Amgen, a leading company that delivers important, cost effective therapeutics based on cellular and molecular biology.
  
  
  
  
  
  
  
• Mr. Jeffrey Sheldon, Licensing and Patent Attorney, is with Sheldon Mak Rose & Anderson, a prominent law firm in Southern California.
• Davis Thompson, Corporate Attorney, is with Atkinson, Andelson, Loya, Ruud and Romo, a prominent law firm in Southern California.